Clinical Trial Update: Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children [Phase 3]

View source ↗

Summary

Phase 3 trial update for fesoterodine and oxybutynin XR in children with overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)
• oxybutynin XL (oxybutynin)

Snippet

Sponsor: Stéphane Bolduc | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED